| Guidance for Endoscopic Procedures in Patients Taking Novel Oral Anticoagulants |
|
Kyoung Oh Kim |
|
Department of Internal Medicine, Gachon University College of Medicine, Incheon, Korea. kkoimge@naver.com |
| 내시경 시술 시 고려사항(길잡이): Novel Oral Anticoagulants 복용 중인 환자에서 |
|
김경오 |
|
가천대학교 의과대학 내과학교실 |
|
Received: 21 November 2016 • Accepted: 8 December 2016 |
| Abstract |
|
Anticoagulant agents are used to reduce the risk of thromboembolic complications in patients with atrial fibrillation or deep vein thrombosis. Several new generation of oral anticoagulants have been approved. These novel oral anticoagulants (NOACs) include direct thrombin inhibitors, dabigatra etexilate, and the direct factor Xa inhibitors, rivaroxaban, apixaban and edoxaban. This review evaluates NOACs-related gastrointestinal bleeding and summarizes the ideal management strategies based on the guideline suggested by American Society for Gastrointestinal Endoscopy. |
| Key Words:
Anticoagulants; Endoscopy; Gastrointestinal hemorrhage; Thromboembolism |
PDF Links
Full text via DOI
Download Citation
